Abstract
A series of phenylalanine derivatives were synthesized and their biological activities were evaluated. Compounds (S)-3 and (R)-3 exhibited more potent insulin-releasing activity than that of nateglinide, compound (S)-3 also showed insulin-sensitizing activity in vitro. Both compounds were tested for hypoglycemia effect in vivo.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Line
-
Cricetinae
-
Drug Design
-
Hypoglycemic Agents / chemistry*
-
Hypoglycemic Agents / pharmacology*
-
Insulin / metabolism*
-
Mice
-
Phenylalanine / analogs & derivatives*
-
Phenylalanine / pharmacology*
Substances
-
Hypoglycemic Agents
-
Insulin
-
Phenylalanine